Published in J Virol on October 24, 2007
Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. J Virol (2008) 1.83
Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol (2013) 1.08
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology (2011) 1.07
The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One (2009) 1.06
Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. Cell Logist (2011) 1.06
Accessories to the crime: recent advances in HIV accessory protein biology. Curr HIV/AIDS Rep (2009) 0.96
Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M. J Virol (2013) 0.95
The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells. PLoS One (2014) 0.87
Preserved MHC class II antigen processing in monocytes from HIV-infected individuals. PLoS One (2010) 0.82
Viral factors in non-progression. Front Immunol (2013) 0.82
Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release. Biophys J (2010) 0.80
Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail. PLoS One (2012) 0.80
Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu. J Virol (2011) 0.79
Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag. PLoS One (2010) 0.77
The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species. Sci Rep (2016) 0.76
Efficient Vpu-mediated tetherin antagonism by an HIV-1 group O strain. J Virol (2017) 0.75
Alternatively Spliced Human TREK-1 Variants Alter TREK-1 Channel Function and Localization. Biol Reprod (2015) 0.75
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell (1996) 11.22
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med (1996) 7.08
A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science (1988) 6.30
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell (1998) 5.89
Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A (1989) 5.72
Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol (1992) 5.05
Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (1990) 5.02
MIF signal transduction initiated by binding to CD74. J Exp Med (2003) 4.79
Viral strategies of immune evasion. Science (1998) 4.48
A viral inhibitor of peptide transporters for antigen presentation. Nature (1995) 4.26
Identification of a protein encoded by the vpu gene of HIV-1. Nature (1988) 4.05
HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog (2006) 3.97
An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell (1985) 3.88
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci U S A (1993) 3.63
The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol (1996) 3.56
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc Natl Acad Sci U S A (2003) 3.05
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med (1998) 2.49
CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol (1998) 2.38
Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol (1995) 2.22
HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A (2001) 2.14
Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat Med (2002) 2.13
Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel. Mol Cell (2004) 2.05
The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J Virol (1996) 2.01
The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic (2006) 1.97
The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol (1994) 1.93
The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J Biol Chem (2001) 1.69
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J Virol (2003) 1.61
The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med (1997) 1.55
Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta (2002) 1.46
CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol Biol Cell (2005) 1.42
The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J Exp Med (2001) 1.38
Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology (2002) 1.34
Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J Gen Virol (1997) 1.25
The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem (2004) 1.24
The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release. Microbes Infect (2003) 1.24
The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol (2005) 1.20
Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res (2006) 1.14
Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J Immunol (2003) 1.11
Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J Virol (1999) 1.07
Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res Hum Retroviruses (2001) 1.00
Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques. Virology (1999) 1.00
Recent advances in the understanding of HIV-1 Vpu accessory protein functions. Curr Drug Targets Immune Endocr Metabol Disord (2004) 0.94
A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86. Cell Host Microbe (2007) 0.89
Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules. Immunology (2002) 0.88
Interaction of human immunodeficiency virus type 2 Vpx and invariant chain. J Virol (2000) 0.85
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature (2010) 6.87
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature (2009) 6.65
Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity (2009) 5.10
Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell (2010) 4.57
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity (2011) 3.38
Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol (2009) 2.17
Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol (2012) 2.10
Molecular biology and pathogenesis of hepatitis E virus. J Biosci (2008) 1.85
Hepatitis E. Hepatology (2011) 1.84
Molecular virology of hepatitis E virus. Virus Res (2011) 1.80
The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J Biol Chem (2002) 1.52
The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J Biol Chem (2004) 1.41
The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem (2004) 1.24
Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection. PLoS Pathog (2008) 1.22
Biology of the HIV Nef protein. Indian J Med Res (2005) 1.20
The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol (2005) 1.20
Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2006) 1.16
The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem J (2004) 1.16
The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol (2008) 1.15
Molecular virology of hepatitis E virus. Semin Liver Dis (2013) 1.12
Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol (2009) 1.12
Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Res (2003) 1.09
The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA. J Virol (2004) 1.07
The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem (2007) 1.07
The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP. Cell Microbiol (2009) 1.06
Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway. J Cell Biol (2008) 1.06
Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol (2007) 1.06
The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One (2009) 1.06
Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol (2006) 1.04
Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif. J Biol Chem (2005) 1.04
Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J Virol (2007) 1.03
The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J Cell Sci (2004) 1.02
Hepatitis E vaccine. Hepatol Int (2008) 1.01
Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF. Proteome Sci (2011) 0.97
The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference. PLoS One (2013) 0.94
The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol (2010) 0.94
Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus. Biochem Biophys Res Commun (2004) 0.92
Purification and diagnostic utility of a recombinant hepatitis E virus capsid protein expressed in insect larvae. Protein Expr Purif (2003) 0.91
Adaptive immune responses during acute uncomplicated and fulminant hepatitis E. J Gastroenterol Hepatol (2011) 0.90
HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol (2009) 0.89
The hepatitis E virus ORF3 protein regulates the expression of liver-specific genes by modulating localization of hepatocyte nuclear factor 4. PLoS One (2011) 0.89
A C-Terminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid (ORF2) Protein. J Biomed Biotechnol (2001) 0.89
A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86. Cell Host Microbe (2007) 0.89
Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein--a genetic, biochemical and biophysical analysis. Virol J (2007) 0.89
Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virol J (2006) 0.88
Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol (2008) 0.87
Consensus proposals for classification of the family Hepeviridae. J Gen Virol (2015) 0.87
Plasma and urine biomarkers in acute viral hepatitis E. Proteome Sci (2009) 0.87
HIV-1 Nef induces a Rab11-dependent routing of endocytosed immune costimulatory proteins CD80 and CD86 to the Golgi. Traffic (2008) 0.86
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals. Retrovirology (2013) 0.86
Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages. Virol J (2007) 0.85
Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy. PLoS One (2013) 0.84
Virus entry paradigms. Amino Acids (2009) 0.84
Hepatitis E virus genotype 1, Cuba. Emerg Infect Dis (2008) 0.82
Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway. Traffic (2015) 0.82
Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin. J Gen Virol (2007) 0.82
Apoptosis-inducing factor regulates death in peripheral T cells. J Immunol (2007) 0.81
Pandemic flu: from the front lines. Interviewed by Declan Butler. Nature (2009) 0.80
Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma. World J Gastroenterol (2006) 0.80
Renal replacement lipomatosis with coexisting xanthogranulomatous pyelonephritis in a pregnant woman. Iran J Kidney Dis (2011) 0.79
Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cells. PLoS One (2013) 0.79
Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology (2010) 0.78
Obliterative bronchiolitis in a patient with myelodysplastic syndrome before bone marrow transplantation. Respir Med (2006) 0.78
Molecular dynamics simulations reveal the HIV-1 Vpu transmembrane protein to form stable pentamers. PLoS One (2013) 0.77
Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. J Clin Virol (2008) 0.77
Hepatitis E viruses. Foreword. Virus Res (2011) 0.77
Putting T cells to sleep: a new paradigm for immune evasion by persistent viruses. J Biosci (2006) 0.76
Prevention of contamination by xenotropic murine leukemia virus-related virus: susceptibility to alcohol-based disinfectants and environmental stability. Appl Environ Microbiol (2014) 0.75
Tracheobronchial anomalies in a patient with Schimke immuno-osseous dysplasia (SIOD). Am J Med Genet A (2014) 0.75
Purification of an Enterobacter aerogenes plasmid DNA using MnCl2 as compaction agent. Anal Biochem (2003) 0.75
Corrigendum: Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature (2017) 0.75
The birds are coming: are we ready? Indian J Med Res (2005) 0.75
Hepatitis E virus in bottlenose dolphins Tursiops truncatus. Dis Aquat Organ (2017) 0.75
Epithelioid cell cluster in cerebrospinal fluid: an unusual finding in tubercular meningitis. Diagn Cytopathol (2009) 0.75